Ultragenyx Pharmaceutical...

35.69
0.71 (2.03%)
At close: Apr 17, 2025, 3:59 PM
35.69
0.00%
After-hours: Apr 17, 2025, 04:31 PM EDT

Ultragenyx Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
560.23M 434.25M 363.33M 351.41M 271.03M 103.71M 51.49M 2.61M 133K
76.73M 45.21M 28.32M 16.01M 6.13M 9.01M 1.15M 1K 183.2M
483.5M 389.04M 335.01M 335.4M 264.9M 94.71M 50.35M 2.61M -183.07M
-535.97M -569.21M -648.92M -381.74M -330.12M -424.17M -371.37M -328.94M -248.01M
36.51M 26.69M 11.07M 1.93M 7.04M 13.24M 9.54M 4.07M 3.79M
-567.59M -608.46M -701.73M -452.98M -185.36M -399.44M -197.1M -318.34M -245.84M
-569.18M -606.64M -707.42M -454.02M -186.57M -402.73M -197.61M -302.14M -245.87M
321.61M 309.8M 278.14M 219.98M 182.93M 161.52M 127.72M 99.91M 64.94M
697.87M 648.45M 705.79M 497.15M 412.08M 357.36M 294M 231.64M 183.2M
n/a n/a 9.51M 241K 7.64M 12.45M 3.95M 10.6M 2.17M
1.02B 958.25M 983.93M 717.13M 595.02M 518.88M 421.72M 331.55M 248.14M
63.04M 66M 43.02M 29.42M 33.29M 1.14M n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
1.1B 1B 1.01B 733.14M 601.15M 527.89M 422.87M 331.55M 248.14M
1.6M -1.82M 5.7M 1.04M 1.21M 3.28M 514K -16.2M 35K
90.54M 73.54M 69.91M 67.8M 60.85M 56.58M 49.78M 42.45M 39.59M
90.54M 73.54M 69.91M 67.8M 60.85M 56.58M 49.78M 42.45M 39.59M
-6.29 -8.25 -10.12 -6.7 -3.07 -7.12 -3.97 -7.12 -6.21
-6.29 -8.25 -10.12 -6.7 -3.07 -7.12 -3.97 -7.12 -6.21
-469M -516.45M -640.51M -410.32M -139.81M -389.77M -177.56M -312.51M -244.58M
-504.55M -542.46M -658.71M -423.56M -152.07M -398.31M -197.1M -318.34M -248.01M
35.54M 26.01M 18.2M 13.24M 12.26M 8.54M 19.54M 5.83M 3.42M